Suggested

Trending

ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
00:03:24

ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Free
207 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
00:02:59

CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Free
234 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
00:08:45

CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Free
133 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
00:03:44

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Free
120 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
0:07:00

Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
Free
0 Views
1 hour ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
0:05:32

Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
Free
6 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
0:02:15

John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
Free
4 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
0:02:51

John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
Free
28 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login